Xeris Biopharma Holdings Inc (XERS)
SBC to Revenue
12.02%
Quarterly · Period ending:
XERS SBC to Revenue
Latest reported12.02%period ending
Latest reported12.02%period ending
XERS Quarterly SBC/Revenue (44.63% → 12.02%)
Latest values, visible window
High-resolution chart · PNG
XERS sbc to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 12.0152% | |
| 4.9803% | |
| 6.144% | |
| 10.2756% | |
| 7.0004% | |
| 7.3903% | |
| 5.9818% | |
| 12.4714% | |
| 8.8068% | |
| 9.2696% | |
| 6.2334% | |
| 5.0849% | |
| 7.7036% | |
| 7.7238% | |
| 8.3454% | |
| 9.894% | |
| 12.4555% | |
| 14.9549% | |
| 12.6586% | |
| 33.2125% | |
| 28.2057% | |
| 30.0305% | |
| 29.8383% | |
| 21.7401% | |
| 102.1707% | |
| 112.3043% | |
| 98.8197% | |
| 555.418% | |
| 531.5625% | |
| 462.5% | |
| 72.2846% | |
| 93.4708% | |
| 44.0781% | |
| 92.7757% | |
| 31.6916% | |
| 61.1765% | |
| 15.7522% | |
| 44.6328% |